Literature DB >> 24177028

Translational repression of SLC26A3 by miR-494 in intestinal epithelial cells.

Arivarasu N Anbazhagan1, Shubha Priyamvada, Anoop Kumar, Daniel B Maher, Alip Borthakur, Waddah A Alrefai, Jaleh Malakooti, John H Kwon, Pradeep K Dudeja.   

Abstract

SLC26A3 [downregulated in adenoma (DRA)] is a Cl(-)/HCO3(-) exchanger involved in electroneutral NaCl absorption in the mammalian intestine. Altered DRA expression levels are associated with infectious and inflammatory diarrheal diseases. Therefore, it is critical to understand the regulation of DRA expression. MicroRNAs (miRNAs) are endogenous, small RNAs that regulate protein expression via blocking the translation and/or promoting mRNA degradation. To investigate potential modulation of DRA expression by miRNA, five different in silico algorithms were used to predict the miRNAs that target DRA. Of these miRNAs, miR-494 was shown to have a highly conserved putative binding site in the DRA 3'-untranslated region (3'-UTR) compared with other DRA-targeting miRNAs in vertebrates. Transfection with pmirGLO dual luciferase vector containing DRA 3'-UTR (pmirGLO-3'-UTR DRA) resulted in a significant decrease in relative luciferase activity compared with empty vector. Cotransfection of the DRA 3'-UTR luciferase vector with a miR-494 mimic further decreased luciferase activity compared with cells transfected with negative control. The transfection of a miR-494 mimic into Caco-2 and T-84 cells significantly increased the expression of miR-494 and concomitantly decreased the DRA protein expression. Mutation of the seed sequences for miR-494 in 3'-UTR of DRA abrogated the effect of miR-494 on 3'-UTR. These data demonstrate a novel regulatory mechanism of DRA expression via miR-494 and indicate that targeting this microRNA may serve to be a potential therapeutic strategy for diarrheal diseases.

Entities:  

Keywords:  3′-UTR; DRA; microRNA

Mesh:

Substances:

Year:  2013        PMID: 24177028      PMCID: PMC3920076          DOI: 10.1152/ajpgi.00222.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  49 in total

1.  MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells.

Authors:  Guillaume Dalmasso; Hang Thi Thu Nguyen; Yutao Yan; Hamed Laroui; Moiz A Charania; Tracy S Obertone; Shanthi V Sitaraman; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

2.  Prediction of both conserved and nonconserved microRNA targets in animals.

Authors:  Xiaowei Wang; Issam M El Naqa
Journal:  Bioinformatics       Date:  2007-11-29       Impact factor: 6.937

3.  MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function.

Authors:  Lindsay B McKenna; Jonathan Schug; Anastassios Vourekas; Jaime B McKenna; Nuria C Bramswig; Joshua R Friedman; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2010-07-24       Impact factor: 22.682

4.  CFTR induces the expression of DRA along with Cl(-)/HCO(3)(-) exchange activity in tracheal epithelial cells.

Authors:  V J Wheat; H Shumaker; C Burnham; G E Shull; J R Yankaskas; M Soleimani
Journal:  Am J Physiol Cell Physiol       Date:  2000-07       Impact factor: 4.249

5.  Identification of microRNAs associated with ileal and colonic Crohn's disease.

Authors:  Feng Wu; Simin Zhang; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Stephen J Meltzer; Steven R Brant; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

6.  The Role of MicroRNA in Inflammatory Bowel Disease.

Authors:  Sushila R Dalal; John H Kwon
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-11

7.  Transport properties of the human intestinal anion exchanger DRA (down-regulated in adenoma) in transfected HEK293 cells.

Authors:  Georg Lamprecht; Susannah Baisch; Elena Schoenleber; Michael Gregor
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

8.  MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF.

Authors:  Neda Mosakhani; Leo Lahti; Ioana Borze; Marja-Liisa Karjalainen-Lindsberg; Jari Sundström; Raija Ristamäki; Pia Osterlund; Sakari Knuutila; Virinder Kaur Sarhadi
Journal:  Cancer Genet       Date:  2012-10-23

9.  Lactobacillus acidophilus stimulates the expression of SLC26A3 via a transcriptional mechanism.

Authors:  Geetu Raheja; Varsha Singh; Ke Ma; Redouane Boumendjel; Alip Borthakur; Ravinder K Gill; Seema Saksena; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-31       Impact factor: 4.052

10.  Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes.

Authors:  Marina N Chernova; Lianwei Jiang; Boris E Shmukler; Clifford W Schweinfest; Paola Blanco; Steven D Freedman; Andrew K Stewart; Seth L Alper
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

View more
  10 in total

1.  Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3.

Authors:  Ram Lakhan; Veedamali S Subramanian; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-09-14       Impact factor: 4.052

2.  Posttranscriptional regulation of thiamin transporter-1 expression by microRNA-200a-3p in pancreatic acinar cells.

Authors:  Kalidas Ramamoorthy; Kasin Yadunandam Anandam; Tomoya Yasujima; Padmanabhan Srinivasan; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-07-20       Impact factor: 4.052

3.  miR-125a-5p: a novel regulator of SLC26A6 expression in intestinal epithelial cells.

Authors:  Arivarasu N Anbazhagan; Shubha Priyamvada; Alip Borthakur; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2019-05-01       Impact factor: 4.249

4.  Serotonin transporter untranslated regions influence mRNA abundance and protein expression.

Authors:  Christopher Manzella; Megha Singhal; Max Ackerman; Waddah A Alrefai; Seema Saksena; Pradeep K Dudeja; Ravinder K Gill
Journal:  Gene Rep       Date:  2019-10-29

5.  HEK-293 cells expressing the cystic fibrosis transmembrane conductance regulator (CFTR): a model for studying regulation of Cl- transport.

Authors:  Jada C Domingue; Mei Ao; Jayashree Sarathy; Alvin George; Waddah A Alrefai; Deborah J Nelson; Mrinalini C Rao
Journal:  Physiol Rep       Date:  2014-09-28

6.  Mechanism(S) Involved in the Colon-Specific Expression of the Thiamine Pyrophosphate (Tpp) Transporter.

Authors:  Svetlana M Nabokina; Mel Brendan Ramos; Hamid M Said
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

7.  Opposing activities of oncogenic MIR17HG and tumor suppressive MIR100HG clusters and their gene targets regulate replicative senescence in human adult stem cells.

Authors:  Mary F Lopez; Ping Niu; Lu Wang; Maryann Vogelsang; Meenakshi Gaur; Bryan Krastins; Yueqiang Zhao; Aibek Smagul; Aliya Nussupbekova; Aikan A Akanov; I King Jordan; Victoria V Lunyak
Journal:  NPJ Aging Mech Dis       Date:  2017-04-20

Review 8.  MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells.

Authors:  Colleen Yi; Ai-Ming Yu
Journal:  Front Mol Biosci       Date:  2022-06-09

9.  miR-29a, b, and c regulate SLC5A8 expression in intestinal epithelial cells.

Authors:  Arivarasu N Anbazhagan; Shubha Priyamvada; Anoop Kumar; Dulari Jayawardena; Alip Borthakur; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-07       Impact factor: 4.871

Review 10.  The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability.

Authors:  Sarah Stiegeler; Kevin Mercurio; Miruna Alexandra Iancu; Sinéad C Corr
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.